|
2024 |
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials
|
Rodríguez-Arbolí E |
Rodríguez-Arbolí E, Lee CJ, Caballero-Velázquez T, Martínez C, García-Calderón C, Jiménez-León MR, Bermúdez-Rodríguez MA, López-Corral L, Triguero A, Onstad L, Horwitz ME, Sarantopoulos S, Lee SJ, Pérez-Simón JA |
Clin Cancer Res. 2023 Oct 13;29(20):4057-4067. doi: 10.1158/1078-0432.CCR-23-0666. PMID: 37698881. |
11.5 |
Ver artículo
|
|
2024 |
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies.
|
Fox ML |
Fox ML, García-Cadenas I, Navarro V, Martínez AP, Kara M, Bazán IS, Ferra Coll C, Bailén R, Bento L, Parody R, Esquirol A, Ortí G, Mussetti A, Salamero O, Martino R, González AP, Barba P, Kwon M, Solano C, Bosch F, Valcárcel D; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). |
Bone Marrow Transplant. 2024 Jun 24. doi: 10.1038/s41409-024-02322-2. Epub ahead of print. PMID: 38914883 |
4.5 |
Ver artículo
|
|
2024 |
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
|
Piñana JL |
Piñana JL, Vazquez L, Heras I, Aiello TF, Lopez-Corral L, Arroyo I, Soler-Espejo E, Garc?a-Cadenas I, Garcia-Gutierrez V, Aroca C, Chorao P, Olave MT, Lopez-Jimenez J, Gomez MA, Arellano E, Cuesta-Casas M, Avendaño-Pita A, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Mico-Cerda M, Guerreiro M, Morell J, Rodriguez-Galvez P, Labrador J, Campos D, Cedillo A, Vidal CG, Martino R and Solano C |
Front. Oncol. 14:1389345. doi: 10.3389/fonc.2024.1389345 |
3.5 |
Ver artículo
|
|
2024 |
REAL-WORLD EXPERIENCE OF ISAVUCONAZOLE IN ALLOGENEIC STEM CELL TRANSPLANTATION IN SPAIN
|
Kwon M |
Kwon M, Gómez-Centurión I, Oarbeascoa G, Torres M, Martinez AP, Suarez-Lledó M, Chinea A, Cascón MJP, Vazquez L, Espigado I, Izquierdo I, Parody R, Cadenas IG, Calbacho M, Sierra PG, Heras I, Yañez L, Torrent A, Bautista G, Gonzalez S, Roldan E, Vallejo JC, Bailen R, Borrero A, Lopez-Jiménez J, Casas MAC, Solano C; on behalf of the Spanish Group of Hematopoietic Stem Cell Transplantation and Cell Therapy (GETH-TC) |
Transplant Cell Ther. 2024 Jun 11:S2666-6367(24)00467-6. doi: 10.1016/j.jtct.2024.06.009. Epub ahead of print. PMID: 38871055. |
3.2 |
Ver artículo
|
|
2024 |
SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE AFTER UNMANIPULATED HAPLOIDENTICAL HSCT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE: A STUDY ON BEHALF OF THE SPANISH HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELLULAR THERAPY GROUP (GETH)
|
Gómez-Centurión I |
Gómez-Centurión I, Gallardo Morillo AI, Pérez Martínez A, Cabrero Calvo M, Chinea A, González L, Pedraza A, Jiménez Lorenzo MJ, Robles MC, Bailén R, Cascón MJP, Cabero A, Piñana Sánchez JL, Luna A, Perera Alvarez M, Rovira M, Torrent Catarineu A, Sánchez-Pina J, Kwon M |
Transplant Cell Ther. 2024 Jun 6:S2666-6367(24)00440-8. doi: 10.1016/j.jtct.2024.06.003. Epub ahead of print. PMID: 38851323 |
3.2 |
Ver artículo
|
|
2024 |
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia
|
Mora E |
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Español de Trasplante Hematopoyético (GETH) |
Bone Marrow Transplant. 2024 May 16. doi: 10.1038/s41409-024-02298-z. Epub ahead of print. PMID: 38755458 |
5.48 |
Ver artículo
|
|
2024 |
Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC
|
Fonseca-Santos M |
Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, García-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortés-Rodriguez M, Yañez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Español de Trasplante Hematopoyético y Terapia Celular |
Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000005034. Epub ahead of print. PMID: 38685204 |
6.2 |
Ver artículo
|
|
2024 |
Use of eculizumab in pediatric patients with high-risk transplant-associated thrombotic microangiopathy: outcomes and risk factors associated with response and survival. A retrospective study on behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
|
Benítez-Carabante MI |
Benítez-Carabante MI, Bueno D, Alonso García L, López Torija I, Marsal J, Fernandez NavarroJM, Uria Oficialdegui ML, Panesso M, Molina B, Beléndez Bieler C, Palomo P, Pérez Martínez A, Diaz-de-Heredia C |
Transplant Cell Ther. 2024 Mar 21:S2666-6367(24)00292-6. doi: 10.1016/j.jtct.2024.03.019. Epub ahead of print. PMID: 38521410. |
3.2 |
Ver artículo
|
|
2024 |
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial
|
Cabrero M |
Cabrero M, López-Corral L, Jarque I, de la Cruz-Vicente F, Pérez-López E, Valcárcel D, Sanz J, Espigado I, Ortí G, Martín-Calvo C, de la Serna J, Caballero D; Grupo Español de Trasplante Hematopoyético (GETH) and Grupo Español de Linfomas y Trasplante Autólogo (GETH) |
Bone Marrow Transplant. 2024 Mar;59(3):359-365. doi: 10.1038/s41409-023-02171-5. Epub 2024 Jan 2. PMID: 38167647. |
4.8 |
Ver artículo
|
|
2024 |
Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience
|
Alonso García L |
Alonso García L, Bueno Sánchez D, Fernández Navarro JM, Regueiro Garcia A, Blanquer Blanquer M, Benitez Carabante MI, Mozo Del Castillo Y, Fuster Soler JL, Uria Oficialdegui ML, Sisinni L, Perez Martinez A, Diaz de Heredia Rubio C |
Front Immunol. 2024 Feb 1;15:1307932. doi: 10.3389/fimmu.2024.1307932. PMID: 38370416; PMCID: PMC10870648 |
7.3 |
Ver artículo
|
|
2024 |
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
|
Molinos-Quintana Á |
Molinos-Quintana Á, Alonso-Saladrigues A, Herrero B, Caballero-Velázquez T, Galán-Gómez V, Panesso M, Torrebadell M, Delgado-Serrano J, Pérez de Soto C, Faura A, González-Martínez B, Castillo-Robleda A, Diaz-de-Heredia C, Pérez-Martínez A, Pérez-Hurtado JM, Rives S, Pérez-Simón JA |
Front Immunol. 2024 Jan 16;14:1280580. doi: 10.3389/fimmu.2023.1280580 |
5.7 |
Ver artículo
|
|
2023 |
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
|
Piñana JL |
Piñana JL, Heras I, Aiello TF, García-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorão P, Aroca C, García-Vidal C, Arroyo I, Soler-Espejo E, López-Corral L, Avendaño-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hernández-Medina L, González-Santillana C |
Viruses. 2023 Oct 8;15(10):2066. doi: 10.3390/v15102066. PMID: 37896843; PMCID: PMC10612015. |
5.81 |
Ver artículo
|
|
2023 |
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GETH/GETH Study
|
Bastos-Oreiro M |
Bastos-Oreiro M, Gutierrez A, Iacoboni G, López Corral L, Reguera JL, Abrisqueta P, Delgado J, Terol MJ, Hernani R, Martínez N, Ortíz V, Bailen R, Gomez-Centurión I, Caballero A, Sanz J, Guerra Domínguez L, Luzardo H, Mussetti A, Jiménez-Ubieto A, Sancho JM, Sureda A, Pérez A, Barba P, Kwon M, Martín García-Sancho A |
Transplant Cell Ther. 2023 Dec;29(12):747.e1-747.e10. doi: 10.1016/j.jtct.2023.08.026. Epub 2023 Sep 1. PMID: 37659694. |
3.2 |
Ver artículo
|
|
2023 |
Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
|
Galán V |
Galán V, Beléndez C, Echecopar C, Estival P, Sissini L, Olivas R, Bueno D, Molina B, Fuentes C, Regueiro A, Benítez I, Plaza M, Margarit A, Rifón J, Pascual A, Palomo P, Urtasun A, Fuster JL, Díaz de Heredia C, Fernández Navarro JM, González-Vicent M, Ruz B, Pérez-Martínez A |
Transplant Cell Ther. 2023 Nov;29(11):702.e1-702.e11. doi: 10.1016/j.jtct.2023.08.016. Epub 2023 Aug 16. PMID: 37595686 |
3.2 |
Ver artículo
|
|
2023 |
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances
|
Piñana JL |
Piñana JL, Pérez A, Chorão P, Guerreiro M, García-Cadenas I, Solano C, Martino R, Navarro D; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) |
Transpl Infect Dis. 2023 Nov;25 Suppl 1:e14117. doi: 10.1111/tid.14117. Epub 2023 Aug 16. PMID: 37585370 |
2.6 |
Ver artículo
|
|
2023 |
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study
|
Carlos Solano Vercet |
Pedro Castro-Rebollo, 3 Antonio Pérez-Martínez, 4 Lucia López-Corral, 5 Pere Barba-Suñol, 6 Mi Kwon,7 Valentín Ortiz,8 Jaime Sanz-Caballer, 9 Ana Carolina Caballero,10 Joaquín Martínez,11 Ángel Cedillo,12 Anna Sureda13,14 |
BMJ Open |
2.9 |
Ver artículo
|
|
2023 |
Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure
|
Quintero V |
Quintero V, Bueno-Sánchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, López-Duarte M, Pérez-Hurtado JM, Fuster JL, González-Vicent M, Pérez-Martínez A, Diaz-de-Heredia C; Grupo Español de Trasplante de Médula ósea en Niños (GETMON)/Grupo Español de Trasplante Hematopoyético (GETH) and Grupo de Insuficiencias Medulares de la Sociedad Española de Hematología y Oncología Pediátricas (SEHOP) |
Transplant Cell Ther. 2023 Oct;29(10):621.e1-621.e6. doi: 10.1016/j.jtct.2023.07.011. Epub 2023 Jul 15. PMID: 37454760 |
3.2 |
Ver artículo
|
|
2023 |
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination
|
Piñana JL |
Piñana JL, Martino R, Vazquez L, López-Corral L, Pérez A, Chorão P, Avendaño-Pita A, Pascual MJ, Sánchez-Salinas A, Sanz-Linares G, Olave MT, Arroyo I, Tormo M, Villalon L, Conesa-Garcia V, Gago B, Terol MJ, Villalba M, Garcia-Gutierrez V, Cabero A, Hernández-Rivas JÁ, Ferrer E, García-Cadenas I, Teruel A, Navarro D, Cedillo Á, Sureda A, Solano C; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) |
Bone Marrow Transplant. 2023 May;58(5):567-580. doi: 10.1038/s41409-023-01946-0. Epub 2023 Feb 28. PMID: 36854892; PMCID: PMC9974060 |
4.8 |
Ver artículo
|
|
2023 |
Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Childhood Relapsed ALL Board (ReALLNet)
|
Moreno C |
Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Gonzáález Martínez B, Fuentes C, Molinos Á, Guerra-García P, Palomo P, Verdu J, Adán Pedroso RM, Vagace JM, López-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta Á, Lendínez F, Rives S, Pascual A, Rodríguez A, Pérez-Hurtado JM, Fernández JM, Pérez-Martínez A, González-Vicent M, Díaz de Heredia C, Fuster JL |
Front Pediatr. 2023 Mar 20;11:1140637. doi: 10.3389/fped.2023.1140637. PMID: 37020654; PMCID: PMC10067875 |
2.6 |
Ver artículo
|
|
2023 |
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study
|
Averbuch D |
Averbuch D, de la Camara R, Tridello G, Knelange NS, Bykova TA, Ifversen M, Dobsinska V, Ayas M, Hamidieh AA, Pichler H, Perez-Martinez A, Cesaro S, Sundin M, Badell I, Bader P, Johansson JE, Mirci-Danicar O, Sedlacek P, Paillard C, Gibson B, Lawson S, Kroeger N, Corbacioglu S, Mikulska M, Piñana JL, Styczynski J, Ljungman P |
Bone Marrow Transplant. 2023 May;58(5):558-566. doi: 10.1038/s41409-023-01941-5. Epub 2023 Feb 27. PMID: 36849806; PMCID: PMC9969031. |
4.8 |
Ver artículo
|
